Benzodiazepine use, misuse, and abuse: A review
- PMID: 29955458
- PMCID: PMC6007645
- DOI: 10.9740/mhc.2016.05.120
Benzodiazepine use, misuse, and abuse: A review
Abstract
Benzodiazepine (BZD) abuse has reached epidemic levels and results in poor outcomes, particularly when combined with concomitant central nervous system depressants. BZDs are abused most commonly in combination with opioids and alcohol. Emergency department visits and related deaths have soared in recent years. In the absence of other medications or illicit substances, BZDs are rarely the sole cause of death. Prescription drug abuse has received more attention in recent years, yet much remains unknown about BZD abuse. BZDs have low abuse potential in most of the general population. A subset is at elevated risk of abuse, especially those with a history of a substance use disorder. Education, prevention, and identification are vital in reducing BZD abuse.
Keywords: abuse; benzodiazepines; dependence; misuse; overdose; polysubstance abuse.
Conflict of interest statement
Disclosures: This material is the result of work supported with resources and the use of facilities at the Fargo Veterans Affairs Health Care System. The contents do not represent the views of the Department of Veterans Affairs or the US government.
Similar articles
-
Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder.J Subst Abuse Treat. 2017 Jun;77:67-71. doi: 10.1016/j.jsat.2017.03.002. Epub 2017 Mar 9. J Subst Abuse Treat. 2017. PMID: 28476275 Free PMC article.
-
Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists.Am J Emerg Med. 2017 Oct;35(10):1414-1419. doi: 10.1016/j.ajem.2017.04.023. Epub 2017 Apr 14. Am J Emerg Med. 2017. PMID: 28476551 Free PMC article.
-
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1. MMWR Surveill Summ. 2015. PMID: 26469747
-
Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation.Ther Adv Psychopharmacol. 2018 May;8(5):147-168. doi: 10.1177/2045125317753340. Epub 2018 Feb 9. Ther Adv Psychopharmacol. 2018. PMID: 29713452 Free PMC article. Review.
-
The epidemiology of benzodiazepine misuse: A systematic review.Drug Alcohol Depend. 2019 Jul 1;200:95-114. doi: 10.1016/j.drugalcdep.2019.02.033. Epub 2019 May 7. Drug Alcohol Depend. 2019. PMID: 31121495 Free PMC article.
Cited by
-
Changes in Drug Use Patterns during the COVID-19 Pandemic in Italy: Monitoring a Vulnerable Group by Hair Analysis.Int J Environ Res Public Health. 2021 Feb 18;18(4):1967. doi: 10.3390/ijerph18041967. Int J Environ Res Public Health. 2021. PMID: 33670560 Free PMC article.
-
An examination of the medicalization and pharmaceuticalization processes of anxiety and depressive disorders in Belgium between 2004 and 2013: how may both disorders be intertwined?Arch Public Health. 2022 Aug 15;80(1):191. doi: 10.1186/s13690-022-00943-x. Arch Public Health. 2022. PMID: 35971128 Free PMC article.
-
Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis.Front Neurosci. 2024 Apr 25;18:1361692. doi: 10.3389/fnins.2024.1361692. eCollection 2024. Front Neurosci. 2024. PMID: 38726035 Free PMC article.
-
Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis.Pharmacy (Basel). 2025 Jan 22;13(1):7. doi: 10.3390/pharmacy13010007. Pharmacy (Basel). 2025. PMID: 39998006 Free PMC article. Review.
-
Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008-2024) and pipeline phase III medications.Drugs Context. 2025 Apr 3;14:2024-11-2. doi: 10.7573/dic.2024-11-2. eCollection 2025. Drugs Context. 2025. PMID: 40225810 Free PMC article. Review.
References
-
- Wick JY. . The history of benzodiazepines. Consult Pharm. 2013; 28 9: 538- 48. DOI: 10.4140/TCP.n.2013.538 PubMed PMID: 24007886. - DOI - PubMed
-
- Charney DS, Mihic SJ, Harris RA. . Hypnotics and sedatives. : Brunton LL, Lazo JS, Parker KL, . Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. p 401- 27.
-
- American Psychiatric Association. Diagnosis and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Publishing; 2013. p 550- 56.
-
- Olfson M, King M, Schoenbaum M. . Benzodiazepine use in the United States. JAMA Psychiatry. 2015; 72 2: 136- 42. DOI: 10.1001/jamapsychiatry.2014.1763 PubMed PMID: 25517224. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources